Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial. (Q53845273)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial. |
scientific article |
Statements
Safety of serial monthly administration of triple-dose gadopentetate dimeglumine in multiple sclerosis patients: preliminary results of the BECOME trial. (English)
Leo J Wolansky
Mohammad H Haghighi
Evangelia Sevdalis
Stuart D Cook
Nilay Sethi
Jiang Liu
George Joseph
Kimberly Tulloch
Diego Cadavid
1 July 2005
15
3
289-290